Cargando…
Nanoparticle-Based Chimeric Antigen Receptor Therapy for Cancer Immunotherapy
Adoptive cell therapy with chimeric antigen receptor (CAR)-engineered T cells (CAR-Ts) has emerged as an innovative immunotherapy for hematological cancer treatment. However, the limited effect on solid tumors, complex processes, and excessive manufacturing costs remain as limitations of CAR-T thera...
Autores principales: | Shin, Seungyong, Lee, Pyunghwajun, Han, Jieun, Kim, Se-Na, Lim, Jaesung, Park, Dae-Hwan, Paik, Taejong, Min, Junhong, Park, Chun Gwon, Park, Wooram |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Nature Singapore
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9983528/ https://www.ncbi.nlm.nih.gov/pubmed/36867402 http://dx.doi.org/10.1007/s13770-022-00515-8 |
Ejemplares similares
-
Lipid nanoparticle-based mRNA delivery systems for cancer immunotherapy
por: Han, Jieun, et al.
Publicado: (2023) -
Advances in Nanoparticles for Effective Delivery of RNA Therapeutics
por: Byun, Min Ji, et al.
Publicado: (2022) -
Impact of the conjugation of antibodies to the surfaces of polymer nanoparticles on the immune cell targeting abilities
por: Lee, Na Kyeong, et al.
Publicado: (2021) -
Reprogramming the tumor microenvironment with biotechnology
por: Kim, Minjeong, et al.
Publicado: (2023) -
Sepsis diagnosis and treatment using nanomaterials
por: Lim, Jaesung, et al.
Publicado: (2021)